Muzamil Ahmad received his M.S. and Ph.D. degrees in toxicology and neurotoxicology from Hamdard University, New Delhi, India in 1999 and 2003, respectively. Soon after receiving his Ph.D. degree, Dr. Ahmad joined Johns Hopkins University, Baltimore, Md, USA as a Postdoctoral Researcher and worked there until late 2006 and then moved to the University of Pittsburgh School of Medicine as a Research Associate and held joint appointment with Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pa, USA. Dr. Ahmad’s research has mainly focused on neurodegenerative disorders like Parkinson’s disease and stroke. In September 2010, Dr. Ahmad moved back to his native country and became a Faculty Member at the Indian Institute of Integrative Medicine. He is interested in the role played by cyclooxygenase-2 and its products in neurodegeneration and neuroprotection. Dr. Ahmad’s studies focus on how receptors of various prostaglandins and their metabolites regulate cell death after brain injury. Dr. Ahmad’s research interest also includes studies related to potential therapeutic applications of plant-based drugs. The major focus of Dr. Ahmad’s research remains on how various prostaglandins and herbal molecules mitigate cell death in neurodegenerative and neurotoxic conditions and how these molecules regulate neuroinflammatory, oxidative stress, and signaling cascades.
Biography Updated on 1 December 2010